Prime Medicine (PRME) Interest Coverage Ratio (2021 - 2026)
Prime Medicine (PRME) posted Interest Coverage Ratio of 0.28 for Q1 2026, up 100.0% on a QoQ basis from 16202.67 in Q4 2025, and down 8.13% year-over-year from 0.31 in Q1 2025.
Prime Medicine (PRME) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Prime Medicine's Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 0.28 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 8.13% year-over-year to 0.28 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.15 (down 11.89% YoY) and the FY2025 annual result came in at 69450.0, down 6166590.2% from the prior year.
- Interest Coverage Ratio was 0.28 for Q1 2026 at Prime Medicine, up from 16202.67 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.24 in Q1 2024 and bottomed at 16202.67 in Q4 2025.
- A 5-year average of 1103.42 and a median of 0.57 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio soared 99.11% — and 2025, when it sank 6586817.84%.
- Prime Medicine's Interest Coverage Ratio stood at 0.62 in 2022, then climbed by 8.36% to 0.57 in 2023, then jumped by 56.89% to 0.25 in 2024, then sank by 6586817.84% to 16202.67 in 2025, then soared by 100.0% to 0.28 in 2026.
- Business Quant data shows PRME's Interest Coverage Ratio at 0.28 in Q1 2026, 16202.67 in Q4 2025, and 0.75 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Prime Medicine | 525.98 Mn | 525.98 Mn | - | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.28 |
| Dec 31, 2025 | -16,202.67 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -0.27 |
| Mar 31, 2025 | -0.26 |
| Dec 31, 2024 | -0.25 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.27 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -0.57 |
| Sep 30, 2023 | -2.82 |
| Jun 30, 2023 | -1.64 |
| Mar 31, 2023 | -23.79 |
| Dec 31, 2022 | -0.62 |
| Sep 30, 2022 | -316.55 |
| Dec 31, 2021 | -2.38 |